Home › Diffuse Large B-Cell Lymphoma › Virginia › Charlottesville
Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Charlottesville, VA
Isang pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Charlottesville. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Nagre-recruitPhase 2
- University of Virginia Cancer Center, Charlottesville
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Nagre-recruitPhase 3
- University of Virginia Cancer Center ( Site 0138), Charlottesville
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Nagre-recruitPhase 2
- University of Virginia, Charlottesville
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Nagre-recruitPhase 1/2
- University of Virginia Health System, Charlottesville
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
Nagre-recruitPhase 2
- University of Virginia Health System, Charlottesville
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Nagre-recruitPhase 1
- University of Virginia Cancer Center, Charlottesville
A Study of NX-1607 in Adults With Advanced Malignancies
Nagre-recruitPhase 1
- University of Virginia, Charlottesville
Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod
- New York City, NY21 pag-aaral
- Baldwin Park, CA19 pag-aaral
- Chicago, IL18 pag-aaral
- Houston, TX17 pag-aaral
- Los Angeles, CA17 pag-aaral
- Milwaukee, WI16 pag-aaral
- Boston, MA16 pag-aaral
- Philadelphia, PA15 pag-aaral
- Portland, OR15 pag-aaral
- Durham, NC14 pag-aaral
- Nashville, TN14 pag-aaral
- Dallas, TX13 pag-aaral
Iba pang pag-aaral sa Charlottesville
- Non-Small Cell Lung Cancer21 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Kanser sa Prostate15 pag-aaral
- Kanser (lahat ng uri)14 pag-aaral
- Kanser ng Endometrium14 pag-aaral
- Metastatic Cancer13 pag-aaral
- Kanser sa Baga13 pag-aaral
- Pagkabigo ng Puso11 pag-aaral
- Ischemic Stroke10 pag-aaral
- Kanser sa Ovary10 pag-aaral
- Colorectal Cancer10 pag-aaral
- Obesity9 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.